Bronchopulmonary dysplasia
暂无分享,去创建一个
P. Davis | J. Aschner | A. Jobe | M. Laughon | J. Whitsett | S. McGrath-Morrow | B. Thébaud | S. Abman | K. Goss | Robin H. Steinhorn | Roger F. Soll
[1] G. Nijpels,et al. Prognostic models for predicting the risk of foot ulcer or amputation in people with type 2 diabetes: a systematic review and external validation study , 2021, Diabetologia.
[2] Safety Study , 2020, Definitions.
[3] J. Giri,et al. Perceptions of Public and Nonpublic Reporting of Interventional Cardiology Outcomes and Its Impact on Practice: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program , 2019, Journal of the American Heart Association.
[4] J. Pillow,et al. Bronchopulmonary dysplasia: Rationale for a pathophysiological rather than treatment based approach to diagnosis. , 2019, Paediatric respiratory reviews.
[5] B. Poindexter,et al. The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach , 2019, American journal of respiratory and critical care medicine.
[6] J. Pillow,et al. Physiology and Predictors of Impaired Gas Exchange in Infants with Bronchopulmonary Dysplasia. , 2019, American journal of respiratory and critical care medicine.
[7] J. Silvestri,et al. Safety of Intratracheal Administration of Human Umbilical Cord Blood Derived Mesenchymal Stromal Cells in Extremely Low Birth Weight Preterm Infants. , 2019, The Journal of pediatrics.
[8] D. Brousseau,et al. Parent Preferences Regarding Home Oxygen Use for Infants with Bronchopulmonary Dysplasia. , 2019, The Journal of pediatrics.
[9] R. Ohls,et al. Oxygen Disrupts Human Fetal Lung Mesenchymal Cells. Implications for Bronchopulmonary Dysplasia , 2019, American journal of respiratory cell and molecular biology.
[10] B. Poindexter,et al. Early Pulmonary Vascular Disease in Preterm Infants Is Associated with Late Respiratory Outcomes in Childhood , 2019, American journal of respiratory and critical care medicine.
[11] K. Watterberg,et al. Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis. , 2019, The Journal of pediatrics.
[12] A. Avila-Alvarez,et al. Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia , 2019, PloS one.
[13] E. Morrisey,et al. Early lineage specification defines alveolar epithelial ontogeny in the murine lung , 2019, Proceedings of the National Academy of Sciences.
[14] A. Lewandowski,et al. Preterm Birth Is a Novel, Independent Risk Factor for Altered Cardiac Remodeling and Early Heart Failure: Is it Time for a New Cardiomyopathy? , 2019, Current Treatment Options in Cardiovascular Medicine.
[15] Deborah Discenza,et al. Remembering the Power of Stories in Pediatric Research. , 2019, The Journal of pediatrics.
[16] W. Göpel,et al. Genetics of bronchopulmonary dysplasia: When things do not match up, it is only the beginning. , 2019, The Journal of pediatrics.
[17] V. Bhandari,et al. Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics , 2019, Metabolomics.
[18] F. Cools,et al. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial , 2019, JAMA.
[19] Samriddha Ray,et al. Single cell RNA analysis identifies cellular heterogeneity and adaptive responses of the lung at birth , 2019, Nature Communications.
[20] Y. Chang,et al. Neonatal Outcomes of Very Low Birth Weight Infants in Korean Neonatal Network from 2013 to 2016 , 2019, Journal of Korean medical science.
[21] J. Whitsett,et al. Building and Regenerating the Lung Cell by Cell. , 2019, Physiological reviews.
[22] E. Kuhn,et al. Assessment of quality of life in pediatric patients with pulmonary hypertension , 2018, Pulmonary circulation.
[23] L. Kalish,et al. Role of Genetic Susceptibility in the Development of Bronchopulmonary Dysplasia , 2018, The Journal of pediatrics.
[24] Lois E. H. Smith,et al. rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial , 2018, The Journal of pediatrics.
[25] Sean B Fain,et al. Neonatal Pulmonary Magnetic Resonance Imaging of Bronchopulmonary Dysplasia Predicts Short‐Term Clinical Outcomes , 2018, American journal of respiratory and critical care medicine.
[26] S. DeMauro,et al. Living with Severe Bronchopulmonary Dysplasia-Parental Views of Their Child's Quality of Life. , 2018, The Journal of pediatrics.
[27] G. Melen,et al. Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile. , 2018, Cytotherapy.
[28] A. Gaggar,et al. Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia. , 2018, American journal of physiology. Lung cellular and molecular physiology.
[29] R. Savani. Modulators of inflammation in Bronchopulmonary Dysplasia. , 2018, Seminars in perinatology.
[30] R. Keller,et al. Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia. , 2018, Seminars in perinatology.
[31] L. Doyle,et al. An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia. , 2018, Seminars in perinatology.
[32] V. Fainardi,et al. Lung function in a cohort of 5‐year‐old children born very preterm , 2018, Pediatric pulmonology.
[33] S. Bhattacharya,et al. Exome sequencing identifies gene variants and networks associated with extreme respiratory outcomes following preterm birth , 2018, BMC Genetics.
[34] B. Thébaud,et al. Nanotherapies for micropreemies: Stem cells and the secretome in bronchopulmonary dysplasia. , 2018, Seminars in perinatology.
[35] N. Ambalavanan,et al. Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia , 2018, Seminars in perinatology.
[36] R. Morty. Recent advances in the pathogenesis of BPD. , 2018, Seminars in perinatology.
[37] J. Pillow,et al. Increased prevalence of expiratory flow limitation during exercise in children with bronchopulmonary dysplasia , 2018, ERJ Open Research.
[38] S. Kotecha,et al. Persistent and progressive long-term lung disease in survivors of preterm birth. , 2018, Paediatric respiratory reviews.
[39] C. Ito,et al. Impaired Angiogenic Supportive Capacity and Altered Gene Expression Profile of Resident CD146+ Mesenchymal Stromal Cells Isolated from Hyperoxia-Injured Neonatal Rat Lungs. , 2018, Stem cells and development.
[40] A. Malhotra,et al. First‐In‐Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study , 2018, Stem cells translational medicine.
[41] H. Burris,et al. Moving beyond race and ethnicity to understand the effect of inhaled nitric oxide on bronchopulmonary dysplasia prevention. , 2018, The Journal of pediatrics.
[42] R. Wood‐Baker,et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. , 2018, The Lancet. Respiratory medicine.
[43] A. Jobe,et al. Antenatal corticosteroids: an assessment of anticipated benefits and potential risks. , 2018, American journal of obstetrics and gynecology.
[44] W. Oh,et al. Natural History of Postnatal Cardiopulmonary Adaptation in Infants Born Extremely Preterm and Risk for Death or Bronchopulmonary Dysplasia , 2018, The Journal of pediatrics.
[45] M. Palta,et al. Early Pulmonary Vascular Disease in Young Adults Born Preterm , 2018, American journal of respiratory and critical care medicine.
[46] L. Doyle,et al. Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration , 2018, JAMA.
[47] A. Hamvas,et al. Evidence of Echocardiographic Markers of Pulmonary Vascular Disease in Asymptomatic Infants Born Preterm at One Year of Age , 2018, The Journal of pediatrics.
[48] J. Pillow,et al. Lung function trajectories throughout childhood in survivors of very preterm birth: a longitudinal cohort study. , 2018, The Lancet. Child & adolescent health.
[49] S. McGrath-Morrow,et al. Respiratory Phenotypes for Preterm Infants, Children, and Adults: Bronchopulmonary Dysplasia and More , 2018, Annals of the American Thoracic Society.
[50] M. Puhan,et al. Variability of Very Low Birth Weight Infant Outcome and Practice in Swiss and US Neonatal Units , 2018, Pediatrics.
[51] T. Raju,et al. Bronchopulmonary Dysplasia: Executive Summary of a Workshop , 2018, The Journal of pediatrics.
[52] P. Dey,et al. Bronchopulmonary Dysplasia in Preterm Neonates in a Level III Neonatal Unit in India , 2018, Indian Pediatrics.
[53] S. Steele,et al. Pulmonary hypertension in the premature infant population: Analysis of echocardiographic findings and biomarkers , 2018, Pediatric pulmonology.
[54] E. Burchard,et al. Ancestry and Genetic Associations with Bronchopulmonary Dysplasia in Preterm Infants , 2018, bioRxiv.
[55] E. Morrisey,et al. Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor , 2018, Nature.
[56] C. Meisner,et al. Long‐Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia , 2018, The New England journal of medicine.
[57] G. Hall,et al. The impact of respiratory viruses on lung health after preterm birth , 2018, European clinical respiratory journal.
[58] V. Fellman,et al. Lung function after extremely preterm birth—A population‐based cohort study (EXPRESS) , 2018, Pediatric pulmonology.
[59] N. Marlow,et al. Pulmonary Artery Pressures in School‐Age Children Born Prematurely , 2017, The Journal of pediatrics.
[60] F. Harrell,et al. Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension , 2017, JAMA cardiology.
[61] W. Göpel,et al. Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development , 2017, The Journal of pediatrics.
[62] R. Morty,et al. Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia. , 2017, American journal of physiology. Lung cellular and molecular physiology.
[63] N. Finer,et al. Laryngeal Mask Airway for Surfactant Administration in Neonates: A Randomized, Controlled Trial , 2017, The Journal of pediatrics.
[64] H. Olschewski,et al. Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality , 2017, American journal of respiratory and critical care medicine.
[65] B. Thébaud,et al. Bronchopulmonary Dysplasia: Where Have All the Stem Cells Gone?: Origin and (Potential) Function of Resident Lung Stem Cells , 2017, Chest.
[66] L. Doyle,et al. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. , 2017, The Cochrane database of systematic reviews.
[67] D. Moher,et al. Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta‐Analysis of Preclinical Studies , 2017, Stem cells translational medicine.
[68] P. McNamara,et al. Preview : Published ahead of advance online publication Controversies in the identification and management of acute pulmonary hypertension in preterm neonates , 2017 .
[69] C. McEvoy,et al. Can We Prevent Bronchopulmonary Dysplasia? , 2017, The Journal of pediatrics.
[70] Jonathan E. Elliott,et al. Exaggerated Increase in Pulmonary Artery Pressure during Exercise in Adults Born Preterm. , 2017, American journal of respiratory and critical care medicine.
[71] W. Carlo,et al. Using Quality Improvement Tools to Reduce Chronic Lung Disease. , 2017, Clinics in perinatology.
[72] C. Delacourt,et al. Genome-wide association study of bronchopulmonary dysplasia: a potential role for variants near the CRP gene , 2017, Scientific Reports.
[73] B. Poindexter,et al. Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants , 2017, American journal of respiratory and critical care medicine.
[74] P. Shaw,et al. Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study. , 2017, The Journal of pediatrics.
[75] R. Brant,et al. A Time‐Based Analysis of Inflammation in Infants at Risk of Bronchopulmonary Dysplasia , 2018, The Journal of pediatrics.
[76] A. Jobe,et al. Can We Define Bronchopulmonary Dysplasia? , 2017, The Journal of pediatrics.
[77] N. Gotteiner,et al. Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia‐Associated Pulmonary Hypertension , 2017, The Journal of pediatrics.
[78] M. Nishihara,et al. Longitudinal impairment of lung function in school‐age children with extremely low birth weights , 2017, Pediatric pulmonology.
[79] D. Tibboel,et al. The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment , 2017, Front. Med..
[80] D. Mohamed,et al. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age , 2017, JAMA.
[81] L. Palermo,et al. The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1‐Year Corrected Age , 2017, The Journal of pediatrics.
[82] S. Abman,et al. Fetal Vascular Origins of Bronchopulmonary Dysplasia. , 2017, The Journal of pediatrics.
[83] Julie Brown,et al. Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.
[84] Paolo Marchionni,et al. New Insights on Early Patterns of Respiratory Disease among Extremely Low Gestational Age Newborns , 2017, Neonatology.
[85] Jeffrey S. Buzas,et al. Variation in Performance of Neonatal Intensive Care Units in the United States , 2017, JAMA pediatrics.
[86] Shoo K. Lee,et al. Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates , 2017, JAMA pediatrics.
[87] J. Feinstein,et al. Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia , 2017, The Journal of pediatrics.
[88] E. Bancalari,et al. The Evolution of Bronchopulmonary Dysplasia after 50 Years. , 2017, American journal of respiratory and critical care medicine.
[89] R. A. Sinkin,et al. Evidence of Early Pulmonary Hypertension Is Associated with Increased Mortality in Very Low Birth Weight Infants , 2017, American Journal of Perinatology.
[90] B. Vohr,et al. Survival and Neurodevelopmental Outcomes among Periviable Infants , 2017, The New England journal of medicine.
[91] M. Keszler,et al. Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia , 2017, The Journal of pediatrics.
[92] B. Maron,et al. Translational Advances in the Field of Pulmonary Hypertension., Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension , 2017, American journal of respiratory and critical care medicine.
[93] A. V. van Kaam,et al. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. , 2017, The Cochrane database of systematic reviews.
[94] J. Pillow,et al. Altered lung structure and function in mid-childhood survivors of very preterm birth , 2017, Thorax.
[95] L. Gortner,et al. Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study , 2017, PloS one.
[96] A. Regev,et al. Scaling single-cell genomics from phenomenology to mechanism , 2017, Nature.
[97] G. Kadmon,et al. Pulmonary hypertension specific treatment in infants with bronchopulmonary dysplasia , 2017, Pediatric pulmonology.
[98] P. Davis,et al. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants. , 2016, The Cochrane database of systematic reviews.
[99] M. Kumar,et al. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis , 2016, Archives of Disease in Childhood: Fetal and Neonatal Edition.
[100] W. Callaghan,et al. Effects of Maternal Age and Age-Specific Preterm Birth Rates on Overall Preterm Birth Rates - United States, 2007 and 2014. , 2016, MMWR. Morbidity and mortality weekly report.
[101] H. Zar,et al. Respiratory syncytial virus hospitalization and mortality: Systematic review and meta‐analysis , 2016, Pediatric pulmonology.
[102] D. Black,et al. Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns. , 2016, The Journal of pediatrics.
[103] R. Mori,et al. Neonatal Outcomes of Very Low Birth Weight and Very Preterm Neonates: An International Comparison. , 2016, The Journal of pediatrics.
[104] Praveen K. Chandrasekharan,et al. Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach? , 2016, American Journal of Perinatology.
[105] L. García-Marcos,et al. Lung function gain in preterm infants with and without bronchopulmonary dysplasia , 2016, Pediatric pulmonology.
[106] B. Darlow,et al. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants. , 2016, The Cochrane database of systematic reviews.
[107] W. Carlo,et al. The Airway Microbiome at Birth , 2016, Scientific Reports.
[108] S. Abman,et al. Retrospective Analysis of an Interdisciplinary Ventilator Care Program Intervention on Survival of Infants with Ventilator-Dependent Bronchopulmonary Dysplasia , 2016, American Journal of Perinatology.
[109] D. Nicholas,et al. Altered breathing mechanics and ventilatory response during exercise in children born extremely preterm , 2016, Thorax.
[110] G. Shaw,et al. The genetic predisposition to bronchopulmonary dysplasia , 2016, Current opinion in pediatrics.
[111] J. Aschner,et al. Challenges, priorities and novel therapies for hypoxemic respiratory failure and pulmonary hypertension in the neonate , 2016, Journal of Perinatology.
[112] D. Mohamed,et al. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial , 2016, The Lancet.
[113] S. Abman,et al. A Standardized Discharge Process Decreases Length of Stay for Ventilator-Dependent Children , 2016, Pediatrics.
[114] Peter W Zandstra,et al. Quality cell therapy manufacturing by design , 2016, Nature Biotechnology.
[115] R. Green. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia , 2016 .
[116] G. Grunwald,et al. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program , 2016, Circulation.
[117] B. Resch,et al. Prematurity and the burden of influenza and respiratory syncytial virus disease , 2016, World Journal of Pediatrics.
[118] K. Albertine,et al. Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials. , 2016, Current clinical pharmacology.
[119] V. Bhandari,et al. Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia , 2015, Front. Med..
[120] B. Poindexter,et al. Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program. , 2015, Annals of the American Thoracic Society.
[121] N. Ambalavanan,et al. Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia. , 2015, Clinics in perinatology.
[122] P. Mourani,et al. Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia. , 2015, Clinics in perinatology.
[123] S. Kallapur,et al. Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update. , 2015, Clinics in perinatology.
[124] G. Eide,et al. Respiratory illness contributed significantly to morbidity in children born extremely premature or with extremely low birthweights in 1999–2000 , 2015, Acta paediatrica.
[125] M. Hallman,et al. New BPD predicts lung function at school age: Follow‐up study and meta‐analysis , 2015, Pediatric pulmonology.
[126] Jian-Guo Zhou,et al. Mortality and Morbidity of Extremely Low Birth Weight Infants in the Mainland of China: A Multi-center Study , 2015, Chinese medical journal.
[127] C. Meisner,et al. Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia. , 2015, The New England journal of medicine.
[128] R. Romero,et al. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. , 2015, American journal of obstetrics and gynecology.
[129] B. Poindexter,et al. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. , 2015, JAMA.
[130] J. Gould,et al. Determinants of chronic lung disease severity in the first year of life; A population based study , 2015, Pediatric pulmonology.
[131] A. V. van Kaam,et al. Accuracy of the Diagnosis of Bronchopulmonary Dysplasia in a Referral-Based Health Care System. , 2015, The Journal of pediatrics.
[132] A. Jobe. Animal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung Disease , 2015, Front. Med..
[133] W. Göpel,et al. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. , 2015, JAMA pediatrics.
[134] M. Oka,et al. Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial , 2015, Cancer Immunology, Immunotherapy.
[135] M. Rämet,et al. Genes Encoding Vascular Endothelial Growth Factor A (VEGF-A) and VEGF Receptor 2 (VEGFR-2) and Risk for Bronchopulmonary Dysplasia , 2015, Neonatology.
[136] J. Collaco,et al. Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia , 2015, American Journal of Perinatology.
[137] B. Haglund,et al. Perinatal conditions related to growth restriction and inflammation are associated with an increased risk of bronchopulmonary dysplasia , 2015, Acta paediatrica.
[138] W. Hsieh,et al. Neonatal outcomes of extremely preterm infants from taiwan: comparison with Canada, Japan, and the USA. , 2015, Pediatrics and neonatology.
[139] G. Shaw,et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. , 2015, JAMA pediatrics.
[140] J. Whitsett,et al. Diseases of pulmonary surfactant homeostasis. , 2015, Annual review of pathology.
[141] J. Whitsett,et al. Respiratory epithelial cells orchestrate pulmonary innate immunity , 2014, Nature Immunology.
[142] L. Doyle,et al. An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia. , 2014, The Journal of pediatrics.
[143] J. Aschner,et al. L‐citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infants , 2014, Acta paediatrica.
[144] J. Carlin,et al. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation , 2014, BMC Pediatrics.
[145] Elizabeth A. Calle,et al. Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. , 2014, Cell stem cell.
[146] N. Gotteiner,et al. Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension. , 2014, Placenta.
[147] E. Eichenwald,et al. Inhaled Nitric Oxide Increases Urinary Nitric Oxide Metabolites and Cyclic Guanosine Monophosphate in Premature Infants: Relationship to Pulmonary Outcome , 2014, American Journal of Perinatology.
[148] A. Fraser,et al. Cardiovascular function in children who had chronic lung disease of prematurity , 2014, Archives of Disease in Childhood: Fetal and Neonatal Edition.
[149] Hye Soo Yoo,et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. , 2014, The Journal of pediatrics.
[150] B. Schmidt,et al. Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. , 2014, Annals of the American Thoracic Society.
[151] N. Neff,et al. Reconstructing lineage hierarchies of the distal lung epithelium using single cell RNA-seq , 2014, Nature.
[152] L. Ernst,et al. Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: a preterm birth cohort study. , 2014, Early human development.
[153] C. Lal,et al. Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II). , 2014, Birth defects research. Part A, Clinical and molecular teratology.
[154] M. Kemp,et al. Repeated exposure to intra-amniotic LPS partially protects against adverse effects of intravenous LPS in preterm lambs , 2014, Innate immunity.
[155] D. DeMaso,et al. Quality of life and parental adjustment in pediatric pulmonary hypertension. , 2014, Chest.
[156] Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis , 2014, BMJ : British Medical Journal.
[157] A. Jobe,et al. Fetal Immune Response to Chorioamnionitis , 2014, Seminars in Reproductive Medicine.
[158] L. Papile,et al. Respiratory Support in Preterm Infants at Birth , 2014, Pediatrics.
[159] N. Marlow,et al. Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study , 2013, BMC Pediatrics.
[160] R. Dweik,et al. Clinical Characterization and Survival of Patients with Borderline Elevation in Pulmonary Artery Pressure , 2013, Pulmonary circulation.
[161] Yun Cao,et al. Circulating Endothelial Progenitor Cells Decrease in Infants with Bronchopulmonary Dysplasia and Increase after Inhaled Nitric Oxide , 2013, PloS one.
[162] M. Kumar,et al. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis , 2013, BMJ.
[163] B. Thébaud,et al. Stem cell-based therapy for neonatal lung disease—it’s in the juice , 2013, Pediatric Research.
[164] O. Koroglu,et al. Cardiovascular Consequences of Bronchopulmonary Dysplasia in Prematurely Born Preschool Children , 2013, Neonatology.
[165] V. Bhandari,et al. Biomarkers in bronchopulmonary dysplasia. , 2013, Paediatric respiratory reviews.
[166] J. Aschner,et al. Looking beyond PPHN: The Unmet Challenge of Chronic Progressive Pulmonary Hypertension in the Newborn , 2013, Pulmonary circulation.
[167] J. Francis,et al. Right Ventricular Systolic Dysfunction in Young Adults Born Preterm , 2013, Circulation.
[168] G. Badger,et al. Obstetric and Neonatal Care Practices for Infants 501 to 1500 g From 2000 to 2009 , 2013, Pediatrics.
[169] M Gissler,et al. Preterm birth time trends in Europe: a study of 19 countries , 2013, BJOG : an international journal of obstetrics and gynaecology.
[170] C. Kuehni,et al. Catch-up alveolarization in ex-preterm children: evidence from (3)He magnetic resonance. , 2013, American journal of respiratory and critical care medicine.
[171] F. Dunstan,et al. Effect of preterm birth on later FEV1: a systematic review and meta-analysis , 2013, Thorax.
[172] E. Williams,et al. Exercise-induced bronchoconstriction in school-aged children who had chronic lung disease in infancy. , 2013, The Journal of pediatrics.
[173] N. Gotteiner,et al. Fetal Growth Restriction and Pulmonary Hypertension in Premature Infants with Bronchopulmonary Dysplasia , 2012, Journal of Perinatology.
[174] Pablo Lamata,et al. Preterm Heart in Adult Life: Cardiovascular Magnetic Resonance Reveals Distinct Differences in Left Ventricular Mass, Geometry, and Function , 2012, Circulation.
[175] A. Jefferies. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. , 2012, Paediatrics & child health.
[176] M. Hallman,et al. Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure. , 2012, The Journal of pediatrics.
[177] A. Jobe. Effects of chorioamnionitis on the fetal lung. , 2012, Clinics in perinatology.
[178] E. Svensen,et al. Prophylactic versus Selective Use of Surfactant in Preventing Morbidity and Mortality in Preterm Infants , 2012, Neonatology.
[179] G. Buonocore,et al. Oxidative Stress and Bronchopulmonary Dysplasia , 2012, Journal of clinical neonatology.
[180] J. Carlin,et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure , 2012, Archives of Disease in Childhood: Fetal and Neonatal Edition.
[181] H. Halliday,et al. General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: a systematic review. , 2012, Chest.
[182] P. Mourani,et al. Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia , 2012, European Respiratory Journal.
[183] W. Carlo,et al. Prospective Analysis of Pulmonary Hypertension in Extremely Low Birth Weight Infants , 2012, Pediatrics.
[184] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[185] Marius Mada,et al. Alveolarization continues during childhood and adolescence: new evidence from helium-3 magnetic resonance. , 2012, American journal of respiratory and critical care medicine.
[186] F. Polack,et al. Human Rhinoviruses in Severe Respiratory Disease in Very Low Birth Weight Infants , 2012, Pediatrics.
[187] C. Delacourt,et al. Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. , 2011, American journal of respiratory and critical care medicine.
[188] Ahmed A. Mahfouz,et al. Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants. , 2011, Journal of tropical pediatrics.
[189] R. Ehrenkranz,et al. Inhaled Nitric Oxide in Preterm Infants: An Individual-Patient Data Meta-analysis of Randomized Trials , 2011, Pediatrics.
[190] R. Ehrenkranz,et al. Patterns of Blood Protein Concentrations of ELGANs Classified by Three Patterns of Respiratory Disease in the First 2 Postnatal Weeks , 2011, Pediatric Research.
[191] M. Kemp,et al. Chronic Fetal Exposure to Ureaplasma parvum Suppresses Innate Immune Responses in Sheep , 2011, The Journal of Immunology.
[192] L. Hartling,et al. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.
[193] M. Walsh,et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. , 2011, American journal of respiratory and critical care medicine.
[194] A. Jobe. The new bronchopulmonary dysplasia , 2011, Current opinion in pediatrics.
[195] J. Davis,et al. Future applications of antioxidants in premature infants , 2011, Current opinion in pediatrics.
[196] N. Finer,et al. An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonates. , 2010, Journal of aerosol medicine and pulmonary drug delivery.
[197] B. Poindexter,et al. Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.
[198] R. Ehrenkranz,et al. Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants , 2010, Archives of Disease in Childhood: Fetal and Neonatal Edition.
[199] G. Kim,et al. Pulmonary hypertension in infants with bronchopulmonary dysplasia , 2010, Korean journal of pediatrics.
[200] Zhangsheng Yu,et al. Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. , 2010, American journal of respiratory and critical care medicine.
[201] J. Folkman,et al. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. , 2010, The Journal of pediatrics.
[202] E. Bae,et al. Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia , 2010, Korean circulation journal.
[203] S. Archer,et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. , 2009, American journal of respiratory and critical care medicine.
[204] O. Liang,et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. , 2009, American journal of respiratory and critical care medicine.
[205] R. Ehrenkranz,et al. Fetal Growth Restriction and Chronic Lung Disease Among Infants Born Before the 28th Week of Gestation , 2009, Pediatrics.
[206] R. Soll,et al. Animal derived surfactant extract for treatment of respiratory distress syndrome. , 2009, The Cochrane database of systematic reviews.
[207] W. Carlo,et al. Cytokines Associated With Bronchopulmonary Dysplasia or Death in Extremely Low Birth Weight Infants , 2009, Pediatrics.
[208] R. Ehrenkranz,et al. Patterns of Respiratory Disease During the First 2 Postnatal Weeks in Extremely Premature Infants , 2009, Pediatrics.
[209] E. Kajantie,et al. Endostatin Concentration in Cord Plasma Predicts the Development of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants , 2009, Pediatrics.
[210] N. Sugino,et al. MMP‐9 and TIMP‐1 in the cord blood of premature infants developing BPD , 2009, Pediatric pulmonology.
[211] A. Milner,et al. Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia , 2008, Archives of Disease in Childhood Fetal and Neonatal Edition.
[212] K. Jang,et al. Heritability of Bronchopulmonary Dysplasia, Defined According to the Consensus Statement of the National Institutes of Health , 2008, Pediatrics.
[213] Q. Mao,et al. Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants. , 2008, American journal of respiratory and critical care medicine.
[214] Ophir D. Klein,et al. The branching programme of mouse lung development , 2008, Nature.
[215] W. Poole,et al. Predictors of death or bronchopulmonary dysplasia in preterm infants with respiratory failure , 2008, Journal of Perinatology.
[216] A. Gow,et al. Plasma Biomarkers of Oxidative Stress: Relationship to Lung Disease and Inhaled Nitric Oxide Therapy in Premature Infants , 2008, Pediatrics.
[217] P. Donohue,et al. The epidemiology of atypical chronic lung disease in extremely low birth weight infants , 2008, Journal of Perinatology.
[218] Roberto Romero,et al. Epidemiology and causes of preterm birth , 2008, The Lancet.
[219] V. Bhandari,et al. Pulmonary Biomarkers of Bronchopulmonary Dysplasia , 2008, Biomarker insights.
[220] S. Porzio,et al. Epithelial Lining Fluid Neutrophil-Gelatinase-Associated Lipocalin Levels in Premature Newborns with Bronchopulmonary Dysplasia and Patency of Ductus Arteriosus , 2008, International journal of immunopathology and pharmacology.
[221] D. McElhinney,et al. Pulmonary Artery Hypertension in Formerly Premature Infants With Bronchopulmonary Dysplasia: Clinical Features and Outcomes in the Surfactant Era , 2007, Pediatrics.
[222] Arne Ohlsson,et al. Long-term effects of caffeine therapy for apnea of prematurity. , 2007, The New England journal of medicine.
[223] J. Pillow,et al. Bubble continuous positive airway pressure enhances lung volume and gas exchange in preterm lambs. , 2007, American journal of respiratory and critical care medicine.
[224] A. Cipriani,et al. What is an individual patient data meta-analysis? , 2007, Epidemiologia e Psichiatria Sociale.
[225] S. Nanua,et al. Lung cells from neonates show a mesenchymal stem cell phenotype. , 2007, American journal of respiratory and critical care medicine.
[226] B. Thébaud,et al. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. , 2007, American journal of respiratory and critical care medicine.
[227] R. Savani,et al. Inflammatory Markers and Mediators in Tracheal Fluid of Premature Infants Treated With Inhaled Nitric Oxide , 2007, Pediatrics.
[228] J. Carlin,et al. Outcome at 2 Years of Age of Infants From the DART Study: A Multicenter, International, Randomized, Controlled Trial of Low-Dose Dexamethasonef , 2007, Pediatrics.
[229] R. Polin,et al. The Contribution of Intermittent Hypoxemia to Late Neurological Handicap in Mice with Hyperoxia-Induced Lung Injury , 2007, Neonatology.
[230] T. Ogihara,et al. Plasma KL-6 Predicts the Development and Outcome of Bronchopulmonary Dysplasia , 2006, Pediatric Research.
[231] J. Hauth,et al. The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. , 2006, American journal of obstetrics and gynecology.
[232] L. Doyle,et al. Neurodevelopmental outcome of bronchopulmonary dysplasia. , 2006, Seminars in perinatology.
[233] L. Doyle,et al. Caffeine therapy for apnea of prematurity. , 2006, The New England journal of medicine.
[234] C. Romagnoli,et al. Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia , 2006, Intensive Care Medicine.
[235] J. Carlin,et al. Low-Dose Dexamethasone Facilitates Extubation Among Chronically Ventilator-Dependent Infants: A Multicenter, International, Randomized, Controlled Trial , 2006, Pediatrics.
[236] B. Poindexter,et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. , 2005, The Journal of pediatrics.
[237] M. Walsh,et al. Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia , 2005, Pediatrics.
[238] L. Wright,et al. Prolonged Hospital Stay for Extremely Premature Infants: Risk Factors, Center Differences, and the Impact of Mortality on Selecting a Best-Performing Center , 2005, Journal of Perinatology.
[239] D. Carlton,et al. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. , 2005, American journal of respiratory and critical care medicine.
[240] O. Saugstad. Oxidative Stress in the Newborn – A 30-Year Perspective , 2005, Neonatology.
[241] June-Dong Park,et al. Risk factors for the different types of chronic lung diseases of prematurity according to the preceding respiratory distress syndrome , 2005, Pediatrics international : official journal of the Japan Pediatric Society.
[242] A. Sanabria,et al. Randomized controlled trial. , 2005, World journal of surgery.
[243] J. Choi,et al. Clinical characteristics of chronic lung disease without preceding respiratory distress syndrome in preterm infants , 2005, Pediatrics international : official journal of the Japan Pediatric Society.
[244] W. Truog,et al. Dysfunction of Pulmonary Surfactant in Chronically Ventilated Premature Infants , 2004, Pediatric Research.
[245] K. Watterberg,et al. Prophylaxis of Early Adrenal Insufficiency to Prevent Bronchopulmonary Dysplasia: A Multicenter Trial , 2004, Pediatrics.
[246] M. Walsh,et al. Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates , 2004, Pediatrics.
[247] J. Whitsett,et al. Genetic disorders influencing lung formation and function at birth. , 2004, Human molecular genetics.
[248] James E. Morrow. The University of Washington , 2004 .
[249] G. Escobar,et al. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. , 2004, The Journal of pediatrics.
[250] F. Hsieh,et al. Placenta growth factor elevation in the cord blood of premature neonates predicts poor pulmonary outcome. , 2004, Pediatrics.
[251] H. Scholefield,et al. Atypical chronic lung disease in preterm infants , 2004, Journal of perinatal medicine.
[252] B. Vohr,et al. Does labor influence neonatal and neurodevelopmental outcomes of extremely-low-birth-weight infants who are born by cesarean delivery? , 2003, American journal of obstetrics and gynecology.
[253] R. Watkins,et al. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.
[254] S. Abman. Bronchopulmonary dysplasia: "a vascular hypothesis". , 2001, American journal of respiratory and critical care medicine.
[255] W. Poole,et al. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. , 2001, The New England journal of medicine.
[256] W. Truog,et al. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. , 2000, Pediatrics.
[257] P. Chambon,et al. Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli. , 2000, Physiological genomics.
[258] B. Yoder,et al. High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. , 2000, American journal of respiratory and critical care medicine.
[259] R. Bland,et al. Chronic Lung Disease in Early Infancy , 2000 .
[260] N. Voelkel,et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[261] H. Lagercrantz,et al. Early motor and mental development in very preterm infants with chronic lung disease , 2000, Archives of disease in childhood. Fetal and neonatal edition.
[262] N. Finer,et al. Postnatal steroids: short-term gain, long-term pain? , 2000, The Journal of pediatrics.
[263] W. Carlo,et al. Long-Term Follow-up of Premature Infants Treated With Prophylactic, Intratracheal Recombinant Human CuZn Superoxide Dismutase , 2000, Journal of Perinatology.
[264] M. Moore,et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. , 2000, Pediatrics.
[265] J. Hauth,et al. Intrauterine infection and preterm delivery. , 2000, The New England journal of medicine.
[266] D. Schoenfeld,et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.
[267] P. Ballard. Scientific rationale for the use of antenatal glucocorticoids to promote fetal development. , 2000, Pediatrics in review.
[268] M. Rämet,et al. Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. , 2000, American journal of human genetics.
[269] D. Massaro,et al. Retinoic acid treatment partially rescues failed septation in rats and in mice. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[270] D. Warburton,et al. Bioactive Transforming Growth Factor-Beta in the Lungs of Extremely Low Birthweight Neonates Predicts the Need for Home Oxygen Supplementation , 2000, Neonatology.
[271] J. Flynn,et al. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. , 2000, Pediatrics.
[272] T. Bunch,et al. Circulating neutrophil concentration and respiratory distress in premature infants. , 2000, The Journal of pediatrics.
[273] M. G,et al. Randomized trial of Permissive hypercapnia in preterm infants , 2000 .
[274] K. Watterberg,et al. Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. , 2000, Pediatrics.
[275] K. Watterberg,et al. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. , 1999, Pediatrics.
[276] J. Kennedy. Lung function outcome in children of premature birth , 1999, Journal of paediatrics and child health.
[277] A. Jobe. The New BPD: An Arrest of Lung Development , 1999, Pediatric Research.
[278] M. Frid,et al. Subendothelial cells from normal bovine arteries exhibit autonomous growth and constitutively activated intracellular signaling. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[279] T. O'Shea,et al. Risk Factors for Chronic Lung Disease in the Surfactant Era: A North Carolina Population-based Study of Very Low Birth Weight Infants , 1999 .
[280] K. Blyth,et al. Role of Ureaplasma urealyticum in lung disease of prematurity , 1999, Archives of disease in childhood. Fetal and neonatal edition.
[281] B. Yoder,et al. Neonatal chronic lung disease in extremely immature baboons. , 1999, American journal of respiratory and critical care medicine.
[282] E. Bancalari,et al. CLINICAL COURSE AND LUNG FUNCTION ABNORMALITIES DURING DEVELOPMENT OF NEONATAL CHRONIC LUNG DISEASE , 1999 .
[283] S. Saigal. Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant. , 1999, The Journal of pediatrics.
[284] C. Bose,et al. Population-based Study of Chronic Lung Disease in Very Low Birth Weight Infants in North Carolina in 1994 With Comparisons With 1984 , 1999, Pediatrics.
[285] J. Whitsett,et al. Molecular mechanisms controlling lung morphogenesis , 1999, Clinical genetics.
[286] J. Tyson,et al. VITAMIN A SUPPLEMENTATION FOR EXTREMELY-LOW-BIRTH-WEIGHT INFANTS , 1999 .
[287] P. Minoo,et al. Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos. , 1999, Developmental biology.
[288] D. Phelps,et al. Atypical Chronic Lung Disease Patterns in Neonates , 1999, Pediatrics.
[289] A. Salvator,et al. Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant. , 1999, JAMA.
[290] J. Rosenbloom,et al. TGF-beta1 inhibits surfactant component expression and epithelial cell maturation in cultured human fetal lung. , 1998, The American journal of physiology.
[291] R. Soll. Synthetic surfactant for respiratory distress syndrome in preterm infants. , 1998, The Cochrane database of systematic reviews.
[292] A. Husain,et al. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. , 1998, Human pathology.
[293] J. Wispé,et al. Functional and pathological effects of prolonged hyperoxia in neonatal mice. , 1998, American Journal of Physiology.
[294] O. Saugstad,et al. Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD? , 1997, Acta paediatrica.
[295] A. Jobe,et al. Glucocorticoid regulation of surfactant components in immature lambs. , 1997, American journal of physiology. Lung cellular and molecular physiology.
[296] D. Carlton,et al. Role of neutrophils in lung vascular injury and edema after premature birth in lambs. , 1997, Journal of applied physiology.
[297] D. Massaro,et al. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats , 1997, Nature Medicine.
[298] R. Pierce,et al. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. , 1997, The American journal of physiology.
[299] S. Ryan,et al. Prediction of chronic neonatal lung disease on day 4 of life , 1996, European Journal of Pediatrics.
[300] R. Parker,et al. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. , 1996, Seminars in perinatology.
[301] K. Watterberg,et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. , 1996, Pediatrics.
[302] J. Coalson,et al. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. , 1995, American journal of respiratory and critical care medicine.
[303] R. Romero,et al. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. , 1995, American journal of obstetrics and gynecology.
[304] P. Groneck,et al. Inflammatory mediators and bronchopulmonary dysplasia. , 1995, Archives of disease in childhood. Fetal and neonatal edition.
[305] E. Bancalari,et al. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. , 1995, The Journal of pediatrics.
[306] K. Watterberg,et al. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. , 1995, Pediatrics.
[307] R. Levine,et al. Oxidation of proteins in neonatal lungs. , 1994, Pediatrics.
[308] E. Bancalari,et al. Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants. , 1993, The Journal of pediatrics.
[309] T. T. Rhodes,et al. Financial and Emotional Cost Of Bronchopulmonary Dysplasia , 1993, Clinical pediatrics.
[310] J. Davis,et al. Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. , 1993, Journal of applied physiology.
[311] K. Hoppu,et al. Inositol supplementation in premature infants with respiratory distress syndrome. , 1992, The New England journal of medicine.
[312] S. Innis,et al. Intralipid Increases Lung Polyunsaturated Fatty Acids and Protects Newborn Rats from Oxygen Toxicity , 1991, Pediatric Research.
[313] R. Popp,et al. Late pulmonary sequelae of bronchopulmonary dysplasia. , 1990, The New England journal of medicine.
[314] A. Ohlsson,et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. , 1988, Pediatrics.
[315] E. Bancalari,et al. Serial determination of pulmonary function in infants with chronic lung disease. , 1987, The Journal of pediatrics.
[316] W. Morgan,et al. Expiratory flow limitation in infants with bronchopulmonary dysplasia. , 1986, The Journal of pediatrics.
[317] A. Hart. The University of Utah , 1986 .
[318] R. Mellins,et al. Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury. , 1985, The American review of respiratory disease.
[319] J. Fouron,et al. Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. , 1980, Pediatrics.
[320] W. Northway,et al. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.
[321] J. Versalovic,et al. Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review , 2019, The Journal of pediatrics.
[322] A. Agustí,et al. Early Life Origins of Asthma: A Review of Potential Effectors. , 2019, Journal of investigational allergology & clinical immunology.
[323] L. Askie,et al. Race Effects of Inhaled Nitric Oxide in Preterm Infants: An Individual Participant Data Meta‐Analysis , 2018, The Journal of pediatrics.
[324] M. Ericsson,et al. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation , 2018, American journal of respiratory and critical care medicine.
[325] L. Doyle,et al. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. , 2017, The Cochrane database of systematic reviews.
[326] C. McEvoy,et al. Pulmonary Effects of Maternal Smoking on the Fetus and Child: Effects on Lung Development, Respiratory Morbidities, and Life Long Lung Health. , 2017, Paediatric respiratory reviews.
[327] C. Day,et al. Bronchopulmonary dysplasia: new becomes old again! , 2017, Pediatric Research.
[328] Sharon L. Wright,et al. Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide. , 2016, The Journal of pediatrics.
[329] T. Yeh,et al. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia. , 2016, American journal of respiratory and critical care medicine.
[330] B. Poindexter,et al. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. , 2015, American journal of respiratory and critical care medicine.
[331] H. Uhlig,et al. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. , 2014, The Journal of pediatrics.
[332] P. Davis,et al. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. , 2014, The Cochrane database of systematic reviews.
[333] J. Baron,et al. Institute of Child Health and Human Development, National Institutes of Health, Bethesda, , 2014 .
[334] Zhiqun Zhang,et al. Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: a systematic review , 2013, European Journal of Pediatrics.
[335] Yahya Al Ethawi. Elective High-Frequency Oscillatory Ventilation Versus Conventional Ventilation for Acute Pulmonary Dysfunction in Preterm Infants , 2012, Journal of clinical neonatology.
[336] L. Nelin,et al. Chapter 21 – Management of the Infant with Severe Bronchopulmonary Dysplasia , 2012 .
[337] C. O’Donnell,et al. High flow nasal cannula for respiratory support in preterm infants. , 2011, The Cochrane database of systematic reviews.
[338] F. Roelfsema,et al. multi-center study. , 2011 .
[339] V. Preedy,et al. Prospective Cohort Study , 2010 .
[340] W. Carlo,et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. , 2008, American journal of obstetrics and gynecology.
[341] L. Papile. Outcome at 2 Years of Age of Infants From the DART Study: A Multicenter, International, Randomized, Controlled Trial of Low-Dose Dexamethasone , 2008 .
[342] K. Barrington,et al. Inhaled nitric oxide for respiratory failure in preterm infants. , 2001, The Cochrane database of systematic reviews.
[343] P. Burri,et al. Development and growth of the lung , 2007 .
[344] J. Morrow,et al. Inhaled Nitric Oxide Attenuates Hyperoxic Lung Injury in Lambs , 2006, Pediatric Research.
[345] K. Stenmark,et al. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. , 2005, Annual review of physiology.
[346] L. Monte,et al. [Bronchopulmonary dysplasia]. , 2005, Jornal de pediatria.
[347] R. Fry,et al. COVID-19 Infection Risk amongst 14,104 Vaccinated Care Home Residents: A national observational longitudinal cohort study in Wales, United Kingdom, December 2020 to March 2021 , 2021, medRxiv.
[348] Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. , 2002, Paediatrics & child health.
[349] H. Halliday. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. , 2001, The Journal of pediatrics.
[350] C R Bauer,et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. , 2001, Pediatrics.
[351] Bart Nooteboom,et al. An International Comparison , 2000 .
[352] M. Palta,et al. Functional assessment of a multicenter very low-birth-weight cohort at age 5 years. Newborn Lung Project. , 2000, Archives of pediatrics & adolescent medicine.
[353] S. Abman. PULMONARY HYPERTENSION IN CHRONIC LUNG DISEASE OF INFANCY : PATHOGENESIS, PATHOPHYSIOLOGY, AND TREATMENT , 2000 .
[354] K. Stenmark,et al. Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase c isozymes. , 2000, American journal of respiratory cell and molecular biology.
[355] C. Bose,et al. Population-based study of chronic lung disease in very low birth weight infants in North Carolina in 1994 with comparisons with 1984. The North Carolina Neonatologists Association. , 1999, Pediatrics.
[356] T. O'Shea,et al. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. , 1999, Pediatrics.
[357] J. Tyson,et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. , 1998, American journal of obstetrics and gynecology.
[358] D. Cox,et al. alpha1-Proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity: a randomized, controlled trial. , 1998, Pediatrics.
[359] A. Slutsky,et al. VENTILATOR-INDUCED LUNG INJURY : MECHANISMS AND CLINICAL CORRELATES , 1998 .
[360] M. Palta,et al. Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project. , 1998, The Journal of pediatrics.
[361] P. Burri,et al. Postnatal lung development and its impairment by glucocorticoids. , 1997, Pediatric pulmonology. Supplement.
[362] E. Baraldi,et al. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. , 1997, American journal of respiratory and critical care medicine.
[363] J. Zimmerman,et al. Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. , 1996, Critical care medicine.
[364] D. Massaro,et al. Formation of pulmonary alveoli and gas-exchange surface area: quantitation and regulation. , 1996, Annual review of physiology.
[365] P. Burri,et al. Influence of postnatally administered glucocorticoids on rat lung growth. , 1995, Biology of the neonate.
[366] E. Bancalari,et al. Bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.
[367] Joshua Lederberg,et al. Children's Hospital of Philadelphia. , 1975, The Australasian nurses journal.
[368] E. Glaser. The randomized clinical trial. , 1972, The New England journal of medicine.
[369] THE JUICE , 2022 .